Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13DFiled 2 days ago

Neuronetics, Inc.: Chernett Jorey amends Schedule 13D stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13D, sec.gov, 16 November 2026, by SEC EDGAR SCHEDULE 13D

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Chernett Jorey filed an amended Schedule 13D with the SEC (accession 0001193805-26-001478) updating their ownership stake in Neuronetics, Inc. The filing signals a change in a significant shareholder's position in the medical device company. Investors should watch for further detail on the size and direction of the stake adjustment and any stated intent behind it.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13D's report. It can get details wrong, so check the source.

Named in this story

Neuronetics, Inc., Chernett Jorey